Nutex Health Net Worth
Nutex Health Net Worth Breakdown | NUTX |
Nutex Health Net Worth Analysis
Nutex Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Nutex Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Nutex Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Nutex Health's net worth analysis. One common approach is to calculate Nutex Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Nutex Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Nutex Health's net worth. This approach calculates the present value of Nutex Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Nutex Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Nutex Health's net worth. This involves comparing Nutex Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Nutex Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Nutex Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nutex Health's net worth research are outlined below:
| Nutex Health is way too risky over 90 days horizon | |
| Nutex Health appears to be risky and price may revert if volatility continues | |
| Nutex Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 247.65 M. Net Loss for the year was (45.79 M) with profit before overhead, payroll, taxes, and interest of 36.3 M. | |
| About 39.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from investing.com: Freedom Capital Markets bullish on Nutex Health stock |
Nutex Health Quarterly Good Will |
|
Nutex Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nutex Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nutex Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Nutex Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nutex Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nutex Health backward and forwards among themselves. Nutex Health's institutional investor refers to the entity that pools money to purchase Nutex Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Atwood & Palmer Inc | 2024-09-30 | 13.0 | Creative Planning Inc | 2024-06-30 | 0.0 | State Street Corp | 2024-06-30 | 0.0 | Point72 Asia (singapore) Pte. Ltd | 2024-06-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Tower Research Capital Llc | 2024-06-30 | 0.0 | Wealth Enhancement Advisory Services, Llc | 2024-06-30 | 0.0 | Millennium Management Llc | 2024-06-30 | 0.0 | Wealthcare Advisory Partners Llc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 92 K | Essex Investment Management Company, Llc | 2024-09-30 | 72.8 K |
Follow Nutex Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 178.93 M.Market Cap |
|
Project Nutex Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.13) | (0.13) | |
| Return On Capital Employed | (0.09) | (0.09) | |
| Return On Assets | (0.11) | (0.12) | |
| Return On Equity | (0.75) | (0.71) |
When accessing Nutex Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Nutex Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nutex Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Nutex Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nutex Health. Check Nutex Health's Beneish M Score to see the likelihood of Nutex Health's management manipulating its earnings.
Evaluate Nutex Health's management efficiency
Nutex Health has return on total asset (ROA) of 0.0376 % which means that it generated a profit of $0.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.351) %, meaning that it created substantial loss on money invested by shareholders. Nutex Health's management efficiency ratios could be used to measure how well Nutex Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.13 in 2024. Return On Capital Employed is likely to rise to -0.09 in 2024. At this time, Nutex Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 322.8 M in 2024, whereas Total Current Assets are likely to drop slightly above 53.7 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 17.94 | 18.84 | |
| Tangible Book Value Per Share | 9.42 | 9.89 | |
| Enterprise Value Over EBITDA | (25.57) | (26.84) | |
| Price Book Value Ratio | 1.94 | 1.84 | |
| Enterprise Value Multiple | (25.57) | (26.84) | |
| Price Fair Value | 1.94 | 1.84 | |
| Enterprise Value | 7.9 B | 8.3 B |
Understanding the operational decisions made by Nutex Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 1.4906 | Revenue 292 M | Quarterly Revenue Growth 0.256 | Revenue Per Share 60.2 | Return On Equity (0.35) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nutex Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nutex Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nutex Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nutex Health Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 26th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 25th of July 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Nutex Health Earnings per Share Projection vs Actual
Nutex Health Corporate Management
| Vivian MBA | Director Marketing | Profile | |
| BSN JD | Chief Sec | Profile | |
| Elizabeth Hall | HR Mang | Profile | |
| Jon Bates | Chief Officer | Profile | |
| MD MBA | Chairman CEO | Profile | |
| Lawrence FACS | Chief Officer | Profile |
Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.